These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26275383)

  • 1. Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge.
    Cash DM; Frost C; Iheme LO; Ünay D; Kandemir M; Fripp J; Salvado O; Bourgeat P; Reuter M; Fischl B; Lorenzi M; Frisoni GB; Pennec X; Pierson RK; Gunter JL; Senjem ML; Jack CR; Guizard N; Fonov VS; Collins DL; Modat M; Cardoso MJ; Leung KK; Wang H; Das SR; Yushkevich PA; Malone IB; Fox NC; Schott JM; Ourselin S
    Neuroimage; 2015 Dec; 123():149-64. PubMed ID: 26275383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving brain atrophy quantification with deep learning from automated labels using tissue similarity priors.
    Clèrigues A; Valverde S; Oliver A; Lladó X;
    Comput Biol Med; 2024 Sep; 179():108811. PubMed ID: 38991315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images.
    Camara O; Schnabel JA; Ridgway GR; Crum WR; Douiri A; Scahill RI; Hill DL; Fox NC
    Neuroimage; 2008 Aug; 42(2):696-709. PubMed ID: 18571436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian longitudinal segmentation of hippocampal substructures in brain MRI using subject-specific atlases.
    Iglesias JE; Van Leemput K; Augustinack J; Insausti R; Fischl B; Reuter M;
    Neuroimage; 2016 Nov; 141():542-555. PubMed ID: 27426838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
    Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
    Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.
    Ardekani BA; Convit A; Bachman AH
    J Alzheimers Dis; 2016; 50(3):847-57. PubMed ID: 26836168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia.
    Koenig LN; Day GS; Salter A; Keefe S; Marple LM; Long J; LaMontagne P; Massoumzadeh P; Snider BJ; Kanthamneni M; Raji CA; Ghoshal N; Gordon BA; Miller-Thomas M; Morris JC; Shimony JS; Benzinger TLS;
    Neuroimage Clin; 2020; 26():102248. PubMed ID: 32334404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and sensitivity of two whole-brain segmentation approaches included in FreeSurfer - ASEG and SAMSEG.
    Sederevičius D; Vidal-Piñeiro D; Sørensen Ø; van Leemput K; Iglesias JE; Dalca AV; Greve DN; Fischl B; Bjørnerud A; Walhovd KB; Fjell AM;
    Neuroimage; 2021 Aug; 237():118113. PubMed ID: 33940143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration.
    van de Pol LA; Barnes J; Scahill RI; Frost C; Lewis EB; Boyes RG; van Schijndel RA; Scheltens P; Fox NC; Barkhof F
    Neuroimage; 2007 Feb; 34(3):1036-41. PubMed ID: 17174572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
    Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
    Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the onset of structural change in familial Alzheimer's disease.
    Schott JM; Fox NC; Frost C; Scahill RI; Janssen JC; Chan D; Jenkins R; Rossor MN
    Ann Neurol; 2003 Feb; 53(2):181-8. PubMed ID: 12557284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements.
    Lehmann M; Douiri A; Kim LG; Modat M; Chan D; Ourselin S; Barnes J; Fox NC
    Neuroimage; 2010 Feb; 49(3):2264-74. PubMed ID: 19874902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent multi-time-point brain atrophy estimation from the boundary shift integral.
    Leung KK; Ridgway GR; Ourselin S; Fox NC;
    Neuroimage; 2012 Feb; 59(4):3995-4005. PubMed ID: 22056457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI.
    Preboske GM; Gunter JL; Ward CP; Jack CR
    Neuroimage; 2006 May; 30(4):1196-202. PubMed ID: 16380273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel imaging: is GRAPPA a useful acquisition tool for MR imaging intended for volumetric brain analysis?
    Lindholm TL; Botes L; Engman EL; Frank A; Jonsson T; Svensson L; Julin P
    BMC Med Imaging; 2009 Aug; 9():15. PubMed ID: 19650898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
    Hua X; Hibar DP; Ching CR; Boyle CP; Rajagopalan P; Gutman BA; Leow AD; Toga AW; Jack CR; Harvey D; Weiner MW; Thompson PM;
    Neuroimage; 2013 Feb; 66():648-61. PubMed ID: 23153970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenomenological model of diffuse global and regional atrophy using finite-element methods.
    Camara O; Schweiger M; Scahill RI; Crum WR; Sneller BI; Schnabel JA; Ridgway GR; Cash DM; Hill DL; Fox NC
    IEEE Trans Med Imaging; 2006 Nov; 25(11):1417-30. PubMed ID: 17117771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.